Cancer - Revision history

Alexander Berchansky at 13:04, 4 August 2021

2021-08-04T13:04:55Z

← Older revision		Revision as of 13:04, 4 August 2021
Line 20:		Line 20:
	*[[Forkhead box protein M1]]		*[[Forkhead box protein M1]]
	*Growth Factors & Receptors		*Growth Factors & Receptors
			**[[Growth factors\|Growth Factors & Receptors]]
	**[[Autocrine motility factor]]		**[[Autocrine motility factor]]
	**[[Bone morphogenetic protein]]		**[[Bone morphogenetic protein]]

2020-12-01T18:42:10Z

changed Factor Inhibiting HIF for Hypoxia-inducible factors

← Older revision		Revision as of 18:42, 1 December 2020
Line 37:		Line 37:
	**[[Vascular Endothelial Growth Factor]] and [[Vascular Endothelial Growth Factor Receptor]]		**[[Vascular Endothelial Growth Factor]] and [[Vascular Endothelial Growth Factor Receptor]]
	*[[User:Yash_Patankar/Sandbox_1\|Heat Shock Protein 90]]		*[[User:Yash_Patankar/Sandbox_1\|Heat Shock Protein 90]]
	*[[~~Molecular_Playground/FIH~~\|Hypoxia Inducible Factor (HIF)]]		*[[Hypoxia-Inducible_Factors\|Hypoxia Inducible Factor (HIF)]]
	*[[1ebm\|Human 8-Oxoguanine Glycosylase Structure and Mechanism (HOGG1)]]		*[[1ebm\|Human 8-Oxoguanine Glycosylase Structure and Mechanism (HOGG1)]]
	*[[Isocitrate dehydrogenase]]		*[[Isocitrate dehydrogenase]]

2020-01-28T13:55:34Z

← Older revision		Revision as of 13:55, 28 January 2020
Line 7:		Line 7:
	*[[Antizyme Inhibitor]]		*[[Antizyme Inhibitor]]
	*[[Aromatase]]		*[[Aromatase]]
			*The levels of [[Arylamine N-acetyltransferase]] in the body has important consequences with regard to an individual’s susceptibility to certain drug-induced toxicities and cancer. Acetylation is a major route of biotransformation for many arylamines and hydrazine drugs and known carcinogens like cigarette smoke.
	*Caspases		*Caspases
	**[[Molecular_Playground/Caspase-6\|Caspase-6]]		**[[Molecular_Playground/Caspase-6\|Caspase-6]]

2019-12-31T09:15:02Z

← Older revision		Revision as of 09:15, 31 December 2019
Line 45:		Line 45:
	**[[Receptor tyrosine kinases]]		**[[Receptor tyrosine kinases]]
	**Mitogen-Activated Proteins		**Mitogen-Activated Proteins
	***Mitogen-~~Activated Protein Kinase~~		***[[Mitogen-activated protein kinase]]
	***Mitogen-~~Activated Protein Kinase Kinase~~		***[[Mitogen-activated protein kinase kinase]]
	***Mitogen-~~Activated Protein Kinase Kinase Kinase~~		***[[Mitogen-activated protein kinase kinase kinase]]
	*Oncogenes		*Oncogenes
	**[[C-Myc]] - Proto-Oncogenic Gene		**[[C-Myc]] - Proto-Oncogenic Gene

2019-12-30T11:45:32Z

← Older revision		Revision as of 11:45, 30 December 2019
Line 59:		Line 59:
	*[[Sonic Hedgehog]]		*[[Sonic Hedgehog]]
	*[[Tamoxifen]]		*[[Tamoxifen]]
	*[[Molecular_Playground/Taxol\|Taxol Information]]		*Taxol
			**[[Paclitaxel]]
			**[[Molecular_Playground/Taxol\|Taxol Information]]
	*[[Telomerase Reverse Transcriptase]]		*[[Telomerase Reverse Transcriptase]]
	*[[User:Sarah Abdalla/Thioredoxin Reductase\|Thioredoxin Reductase]]		*[[User:Sarah Abdalla/Thioredoxin Reductase\|Thioredoxin Reductase]]

2019-12-11T13:09:37Z

← Older revision		Revision as of 13:09, 11 December 2019
Line 34:		Line 34:
	***[[Tumor necrosis factor receptor]]		***[[Tumor necrosis factor receptor]]
	***[[Tumor necrosis factor ligand superfamily]]		***[[Tumor necrosis factor ligand superfamily]]
	**[[Vascular Endothelial Growth Factor]] and [[Vascular Endothelial Growth Factor Receptor~~]][[Bone morphogenetic protein~~]]		**[[Vascular Endothelial Growth Factor]] and [[Vascular Endothelial Growth Factor Receptor]]
	*[[User:Yash_Patankar/Sandbox_1\|Heat Shock Protein 90]]		*[[User:Yash_Patankar/Sandbox_1\|Heat Shock Protein 90]]
	*[[Molecular_Playground/FIH\|Hypoxia Inducible Factor (HIF)]]		*[[Molecular_Playground/FIH\|Hypoxia Inducible Factor (HIF)]]

2019-12-11T13:08:17Z

← Older revision		Revision as of 13:08, 11 December 2019
Line 30:		Line 30:
	***[[IGF1]]		***[[IGF1]]
	**[[Interleukin]]		**[[Interleukin]]
	**[[Neurotrophin]]
	***[[High affinity nerve growth factor receptor]]
	***[[TrkB tyrosine kinase receptor]]
	**[[Platelet-derived growth factors and receptors]]		**[[Platelet-derived growth factors and receptors]]
	**[[Renalase]] (RNLS) – Anti-apoptotic survival factor
	**[[Tumor necrosis factor]]		**[[Tumor necrosis factor]]
	***[[Tumor necrosis factor receptor]]		***[[Tumor necrosis factor receptor]]

2019-12-11T13:04:49Z

← Older revision		Revision as of 13:04, 11 December 2019
Line 27:		Line 27:
	**[[Growth differentiation factor]]		**[[Growth differentiation factor]]
	**[[Hepatocyte growth factor]] and [[Hepatocyte growth factor receptor]]		**[[Hepatocyte growth factor]] and [[Hepatocyte growth factor receptor]]
	**[[Insulin]] and [[Insulin receptor]]
	**[[Insulin-like growth factor]] and [[Insulin-like growth factor receptor]]		**[[Insulin-like growth factor]] and [[Insulin-like growth factor receptor]]
	***[[IGF1]]		***[[IGF1]]

2019-12-11T13:02:03Z

← Older revision		Revision as of 13:02, 11 December 2019
Line 24:		Line 24:
	**[[Epidermal growth factor]] and [[Epidermal Growth Factor Receptor]]		**[[Epidermal growth factor]] and [[Epidermal Growth Factor Receptor]]
	**[[Ephrin]] and [[Ephrin receptor]]		**[[Ephrin]] and [[Ephrin receptor]]
	**[[Erythropoietin]] and [[Erythropoietin receptor]]
	**[[Fibroblast growth factor]] and [[Fibroblast growth factor receptor]]		**[[Fibroblast growth factor]] and [[Fibroblast growth factor receptor]]
	**[[Growth differentiation factor]]		**[[Growth differentiation factor]]

2019-12-11T13:00:12Z

← Older revision		Revision as of 13:00, 11 December 2019
Line 23:		Line 23:
	**[[Colony-stimulating factor]]		**[[Colony-stimulating factor]]
	**[[Epidermal growth factor]] and [[Epidermal Growth Factor Receptor]]		**[[Epidermal growth factor]] and [[Epidermal Growth Factor Receptor]]
	**[[Platelet-derived growth factors and receptors]]
	**[[Ephrin]] and [[Ephrin receptor]]		**[[Ephrin]] and [[Ephrin receptor]]
	**[[Erythropoietin]] and [[Erythropoietin receptor]]		**[[Erythropoietin]] and [[Erythropoietin receptor]]